Edition:
United States

Ion Beam Applications SA (IBAB.BR)

IBAB.BR on Brussels Stock Exchange

23.22EUR
5:27am EDT
Change (% chg)

€0.38 (+1.66%)
Prev Close
€22.84
Open
€22.90
Day's High
€23.38
Day's Low
€22.86
Volume
6,176
Avg. Vol
73,900
52-wk High
€31.97
52-wk Low
€15.75

Chart for

About

Ion Beam Applications SA (IBA) is a Belgium-based company that develops and markets technologies, pharmaceutical products and tailored solutions for the healthcare sector, with emphasis on cancer diagnosis and therapy. IBA is also active in the sterilization and ionization field. The Company operates through two business... (more)

Overall

Beta: 0.67
Market Cap(Mil.): €685.00
Shares Outstanding(Mil.): 29.99
Dividend: --
Yield (%): --

Financials

  IBAB.BR Industry Sector
P/E (TTM): -- 45.08 30.58
EPS (TTM): -1.34 -- --
ROI: -23.17 7.84 12.84
ROE: -30.21 11.57 15.02

BRIEF-IBA Selected To Install New Proton Therapy Center In Italy

* REG-IBA SA : IBA SELECTED TO INSTALL NEW PROTON THERAPY CENTER IN ITALY

May 03 2018

UPDATE 1-IBA swings to 2017 loss, looks for improvement this year

March 22 Belgian proton therapy company Ion Beam Applications swung to a loss last year and gave only a vague forecast for improvement in 2018, sending its shares sharply lower on Thursday.

Mar 22 2018

IBA posts 39 mln euro FY net loss after 'challenging year'

March 22 Ion Beam Applications posted a net loss for fiscal year 2017, as it concluded a "challenging year" after project delays and higher competition in the proton therapy market, the Belgian company said on Thursday.

Mar 22 2018

BRIEF-Ion Beam Applications FY Net Protif Turns To Loss Of 39.2 Million Euros

* FY REBIT LOSS EUR 11.6 MILLION VERSUS PROFIT EUR 37.1 MILLION YEAR AGO

Mar 22 2018

BRIEF-IBA Signs Three New Contracts With Proton Partners International

* IBA - IBA SIGNS THREE NEW PROTEUS®ONE CONTRACTS WITH PROTON PARTNERS INTERNATIONAL

Mar 12 2018

Earnings vs. Estimates